Keeping pace with the surging global demand for medicines is one of the largest challenges facing the bioprocessing industry today. The dynamic growth and pace of change observed in novel monoclonal antibody formats plus cell and gene therapies emphasizes that biomanufacturing innovation is essential to deliver the scale, speed, and sustainability needed for the future. FUJIFILM Biotechnologies is revolutionizing the bioprocessing industry through our unique, globally harmonized operational ecosystem termed kojoX™ that brings our partners flexibility and unmatched speed to market. Learn more in this white paper from Leon Pybus Ph.D., Associate Director, Cell Culture Process Development: https://lnkd.in/e87F-HZG
About us
For over 30 years, FUJIFILM Biotechnologies' mission has been advancing tomorrow’s medicine. As a CDMO, we work in partnership with the most innovative biopharma and biotech companies across the world who are reimagining healthcare’s potential. We help to accelerate their progress, expand their capabilities, streamline their processes, and strengthen their innovation. So when our customers’ potential cures, vaccines, biologics, and accomplishments make strides – or even become new realities for patients – we know our work, our manufacturing expertise, and our partnership helped make it happen. We aren't simply a workplace. FUJIFILM Biotechnologies a community and place of passion – a place of what we call Genki. A place where diverse perspectives and people come to life. Where opportunity for growth has no end. Where passion is followed, discovered, and nurtured. Where the energy is undeniable, enthusiasm is pervasive, and drive is infectious. All of our global locations burst with curiosity, inspiration, and extraordinary purpose. So as we continue to grow our teams, our global locations, and our capabilities, Genki will always be our cultural tie. That’s why we’re always looking for passionate, mission-driven people who want to commit their life’s work to enabling better outcomes for patients and their families. For a full listing of jobs that will propel, inspire, and fulfill you, please visit: https://fujifilmbiotechnologies.fujifilm.com/careers/ We created this space on LinkedIn to give people a window into our work and culture. We’re highlighting employees’ passion, current openings, and why it’s never been a more exciting time to join!
- Website
- https://fujifilmbiotechnologies.fujifilm.com/
External link for FUJIFILM Biotechnologies
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Morrisville, North Carolina
- Type
- Public Company
- Specialties
- Biologics Process Development and Biologics cGMP Manufacturing
Locations
Employees at FUJIFILM Biotechnologies
Updates
-
FUJIFILM Biotechnologies reposted this
I am excited to announce my membership in The Wall Street Journal CEO Council, where influential leaders gather to shape the future. This platform offers a unique chance to connect with visionaries and develop strategies that drive impactful change. My gratitude goes to the dedicated team at FUJIFILM Biotechnologies, whose hard work fuels our success. Currently attending the WSJ CEO Council Summit 2025 in Washington D.C., it's surreal to be part of such a dynamic and influential community. How we act in the new 2026 Business world and utilize AI to its full potential is key topics of the industry. Together, we're ready to make a significant difference in the industry, pushing boundaries and embracing innovation. #Innovation #WSJ #CEO
-
-
Ready to accelerate your biologics development? In this video, Charles Heise, Associate Director of Bioprocessing Strategy & Development, breaks down how to design with technology, process strategy, and market strategy in mind. You’ll hear practical ways to navigate common technical hurdles, build flexible and scalable processes for fed-batch or continuous modalities, and unlock the opportunities of continuous manufacturing. Whether you’re early in development or optimizing for commercial scale, these insights can help you improve quality, speed, and reliability. Watch now, and remember to like this video and subscribe to our YouTube channel for more expert content. Full interview: https://lnkd.in/eJrfsuDS #Biomanufacturing #ContinuousBioprocessing #ProcessDevelopment #Biologics #CDMO
-
-
The answer was option B! The United Kingdom's Billingham Site was the original site in our network when acquired back in 2011 👏 Congrats to all those who picked correctly!
In the spirit of the holiday season we want to spread fun and cheer with some FUJIFILM Biotechnologies trivia! 🎅 You have 24 hours before the answer is revealed! Our first question:
This content isn’t available here
Access this content and more in the LinkedIn app
-
FUJIFILM Biotechnologies is investing in flexible, digitally enabled manufacturing to meet the rising complexity of novel therapeutics and global supply chain demands. Our kojoX standardized and modular facilities, together with single use suites, enable fast tech transfer, rapid scale out, and consistent quality across our network. By integrating automation, robotics, electronic batch records, advanced analytics, and AI, we improve productivity, predictability, and speed while strengthening compliance and sustainability. These investments support reshoring, supply chain security, and cost efficient delivery for patients and partners. Explore how flexibility creates value in our latest article: https://lnkd.in/eHA7JMuq #Biomanufacturing #Flexible #Manufacturing #Digitalization #Automation #AI #Biotech #CDMO #KojoX #SupplyChain #Sustainability
-
-
FUJIFILM Biotechnologies is helping power North Carolina’s rise as a biomanufacturing leader, with our Holly Springs site showcasing one of the largest commercial scale cell culture operations in North America. In this article, Toshihisa Iida discusses end-to-end capabilities span process development through large scale cGMP manufacturing, supported by the KojoX modular design that drives speed, standardization, and quality. As we continue to invest in new facilities, technologies, and U.S. based production to stay close to patients and partners. Strategic collaborations, including a long term agreement with Johnson and Johnson, affirm our commitment to reliable capacity and innovation. Read the full article to see how FUJIFILM Biotechnologies is shaping the region’s momentum and what it means for the future of biologics manufacturing: https://lnkd.in/eK8gTM89 #Biomanufacturing #NorthCarolina #RaleighDurham #LifeSciences #CDMO #AdvancedManufacturing #KojoX
-
-
Biomanufacturing is rapidly accelerating to meet the demand for complex biologics, powered by AI-driven analytics, continuous processing, targeted integration, and intensified upstream and downstream workflows. In our latest feature article, learn how leaders share real-world perspectives on how these advances are expanding next‑gen modalities and why economic sustainability remains essential. From bispecifics to gene therapies, the pace of progress is redefining what’s possible—improving efficiency, quality, and access for patients. Discover the full story and insights here: https://lnkd.in/ej3iJ-UP #Biomanufacturing #Innovation #Biologics #ProcessIntensification #ContinuousBioprocessing #AI #CDMO #NextGenTherapies
-
-
Launching your biologic or advanced therapy can come with uncertainties. Will the scale and region you manufacture in today give you the agility to meet patient demand tomorrow? FUJIFILM Biotechnologies’ global network with sites in US, UK and EU, combined with our revolutionary kojoX philosophy, can provide the flexibility you need to scale up, down, or out across the globe to address evolving patient demand. Learn how kojoX can help set your biologic or advanced therapy launch up for success, enabling adaptability and supply continuity today and in the future. https://lnkd.in/eBeTJ7gp
-